12/1
06:03 pm
ctkb
Cytek Biosciences (NASDAQ:CTKB) was given a new $6.00 price target on by analysts at Morgan Stanley.
Low
Report
Cytek Biosciences (NASDAQ:CTKB) was given a new $6.00 price target on by analysts at Morgan Stanley.
11/20
05:50 am
ctkb
Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth [Seeking Alpha]
Low
Report
Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth [Seeking Alpha]
11/17
04:43 am
ctkb
Cytek Biosciences (CTKB): Evaluating Valuation After TIME's 2026 Growth Leaders Recognition and Recurring Revenue Momentum [Yahoo! Finance]
High
Report
Cytek Biosciences (CTKB): Evaluating Valuation After TIME's 2026 Growth Leaders Recognition and Recurring Revenue Momentum [Yahoo! Finance]
11/12
05:06 pm
ctkb
TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026 [Yahoo! Finance]
Medium
Report
TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026 [Yahoo! Finance]
11/12
05:00 pm
ctkb
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
Medium
Report
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
11/11
12:21 pm
ctkb
Cytek Biosciences (NASDAQ:CTKB) had its price target lowered by analysts at Piper Sandler from $8.00 to $7.50. They now have an "overweight" rating on the stock.
Low
Report
Cytek Biosciences (NASDAQ:CTKB) had its price target lowered by analysts at Piper Sandler from $8.00 to $7.50. They now have an "overweight" rating on the stock.
11/6
06:10 pm
ctkb
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year [Yahoo! Finance]
Low
Report
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year [Yahoo! Finance]
11/6
05:00 pm
ctkb
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
Medium
Report
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
11/6
04:05 pm
ctkb
Cytek Biosciences to Participate in Upcoming Investor Conferences
Medium
Report
Cytek Biosciences to Participate in Upcoming Investor Conferences
11/6
06:56 am
ctkb
Cytek Biosciences (NASDAQ:CTKB) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Cytek Biosciences (NASDAQ:CTKB) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/5
04:05 pm
ctkb
Cytek Biosciences Reports Third Quarter 2025 Financial Results
High
Report
Cytek Biosciences Reports Third Quarter 2025 Financial Results
10/29
05:00 pm
ctkb
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
Medium
Report
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
10/22
04:35 pm
ctkb
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025 [Yahoo! Finance]
Low
Report
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025 [Yahoo! Finance]
10/22
04:05 pm
ctkb
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
Low
Report
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
10/15
05:00 pm
ctkb
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
Low
Report
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth